Clinical Trial Update: Phase I, Randomized, Double-blinded, Placebo-Controlled Dose De-escalation Study to Evaluate Safety and Immunogenicity of Alum Adjuvanted Zika Virus Purified Inactivated Vaccine (ZPIV) in Adults in a Flavivirus Endemic Area [Phase 1]

View source ↗

Summary

Phase I randomized, double-blind study evaluating safety and immunogenicity of alum-adjuvanted Zika purified-inactivated vaccine (ZPIV) in adults in a flaviviru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Zika Virus Infection

Drugs mentioned

• ZPIV (Zika virus purified-inactivated vaccine) with alum adjuvant (ZPIV)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Zika Virus Infection | Phase 1 | Status: COMPLETED | Results posted: 2023-04-06